| S.No. | Intermediate name | Cas No. | API |
|---|---|---|---|
| 1 | tert-Butyl 4-(5-(4-fluorobenzoyl)pyrimidin-2-yl)piperazine-1-carboxylate | 1703794-73-3 | Avapritinib |
| 2 | (4-fluorophenyl) (2-(piperazin-1-yl)pyrimidin-5-yl)methanone hydrochloride | 1703795-52-1 | Avapritinib |
| 3 | 6-broMopyrrolo [1,2-f] [1,2,4]triazin-(3H)-one | 888721-83-3 | Avapritinib |
| 4 | 4-chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4] triazine | 1703794-33-5 | Avapritinib |
| 5 | 5-((4-Ethylpiperazin-1-yl)methyl)pyridin-2-amine | 1180132-17-5 | Abemaciclib |
| 6 | 6-Bromo-4fluoro--1-isopropyl-2-methyl-1H-benzo[d]imidazole | 1231930-33-8 | Abemaciclib |
| 7 | 2,4-Dichloro-5-fluoropyrimidine | 2927-71-1 | Abemaciclib |
| 8 | (R)-3-Hydroxypyrrolidine | 2799-21-5 | Asciminib |
| 9 | 5-Bromo-6-chloronicotinic acid | 29241-62-1 | Asciminib |
| 10 | 1-(Tetrahydropyran-2-yl)-1H-pyrazole-5-boronic acid pinacol ester | 903550-26-5 | Asciminib |
| 11 | 4-(Chloro-difluoro-methoxy)-phenylamine | 39065-95-7 | Asciminib |
| 12 | 1375541-21-1 | Atogepant | |
| 13 | 1456803-43-2 | Atogepant | |
| 14 | 4-Methyl-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine | 1378865-93-0 | Alpelisib |
| 15 | 1-Bromo-8-chloronaphthalene | 20816-79-9 | Adagrasib |
| 16 | tert-Butyl 2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine-7-carboxylate | 916420-27-4 | Adagrasib |
| 17 | 2-Propenoic acid, 2-fluoro-,sodium sal | 74893-46-2 | Adagrasib |
| 18 | (R)-1-Boc-3-hydroxymethylpiperazine | 278788-66-2 | Adagrasib |
| 19 | 1672665-55-2 | Belzutifan | |
| 20 | 1672665-29-0 | Belzutifan | |
| 21 | 1672668-41-5 | Belzutifan | |
| 22 | 2738675-96-0 | Belzutifan | |
| 23 | 2bromo--N-isopropylacetamide | 75726-96-4 | Belumosudil |
| 24 | 1-Boc-5-aminoindazole | 129488-10-4 | Belumosudil |
| 25 | Phenol, 3-(4-chloro-2-quinazolinyl)-,1-acetate | 911417-24-8 | Belumosudil |
| 26 | N-2: | 911417-26-0 | Belumosudil |
| 27 | (S)-3-Amino-3-(4-chlorophenyl)propan-1-ol | 886061-26-3 | Capivasertib |
| 28 | N-boc-amino-piperidinyl-1,1-carboxylic acid | 252720-31-3 | Capivasertib |
| 29 | 7-(Benzyloxy)-3-bromo-1,2-dihydronaphthalene | 722536-73-4 | Elacestrant |
| 30 | N-(2-bromo-5-methoxyphenyl)acetamide | 123027-99-6 | Elacestrant |
| 31 | N-ethyl-4formyl--Benzeneacetamide | 2477812-42-1 | Elacestrant |
| 32 | 4-Fluoro-2-methylphenylboronic acid | 139911-29-8 | Elinzanetant |
| 33 | 2-(3,5-bis(trifluoro Methyl)phenyl)-2-Methyl propanoic acid | 289686-70-0 | Elinzanetant |
| 34 | (7S,9AS)-Octahydropyrazino [2,1-C] [1,4] Oxazine-7-methanol hcl | Elinzanetant | |
| 35 | 4-Amino-5-methyl-2(1H)-pyridinone | 95306-64-2 | Finerenone |
| 36 | 2-Methoxy-4-cyanobenzaldehyde | 21962-45-8 | Finerenone |
| 37 | (Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate | 1050477-39-8 | Finerenone |
| 38 | (R)-3-methyl-2-ketopiperazine | 922178-61-8 | Fezolinetant |
| 39 | 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | 1375066-73-1 | Fezolinetant |
| 40 | 3-Methyl-[1,2,4]thiadiazole-5-carboxylic acid ethyl ester | 76162-56-6 | Fezolinetant |
| 41 | 1902955-29-6 | Fexuprazan | |
| 42 | 701-27-9 | Fexuprazan | |
| 43 | 2408761-20-4 | Iptacopan | |
| 44 | 1481631-51-9 | Iptacopan | |
| 45 | 1644667-61-7 | Iptacopan | |
| 46 | 2408761-21-5 | Iptacopan | |
| 47 | 2189684-53-3 | Lenacapavir | |
| 48 | 1620056-83-8 | Lenacapavir | |
| 49 | 2189684-54-4 | Lenacapavir | |
| 50 | 1620056-47-4 | Lenacapavir | |
| 51 | 2109226-54-0 | Lenacapavir | |
| 52 | 2375019-75-1 | Lenacapavir | |
| 53 | 3-Phenyl-1H-Pyrazole-4-Carbaldehyde | 26033-20-5 | Lazertininb |
| 54 | 4-fluoro-2-Methoxy-5-nitroaniline | 1075705-01-9 | Lazertininb |
| 55 | 1903009-56-2 | Lazertininb | |
| 56 | 3-Ethyl bicyclo[3.2.0]hept-3-en-6-one | 1235479-59-0 | Mirogabalin |
| 57 | (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one | 1235479-61-4 | Mirogabalin |
| 58 | 1,2,3,5-Tetra-O-Acetyl-Beta-L-Ribofuranose | 144490-03-9 | Maribavir |
| 59 | 2-Bromo-5,6-Dichlorobenzimidazole | 142356-40-9 | Maribavir |
| 60 | 4,5-Dichloro-1,2-benzenediamine | 5348-42-5 | Maribavir |
| 61 | 5-Bromo-4-fluoro-1-methyl-1H-indazole | 1784678-61-0 | Orforglipron |
| 62 | (S)-3-Aminobutanenitrile hydrochloride | 1073666-54-2 | Orforglipron |
| 63 | 2212021-61-7 | Orforglipron | |
| 64 | :2212021-83-3 | Orforglipron | |
| 65 | 769132-28-7 | Obicetrapib | |
| 66 | 952582-00-2 | Obicetrapib | |
| 67 | 952582-02-4 | Obicetrapib | |
| 66 | Tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571188-59-5 | Palbociclib |
| 67 | 6-bromo-2-chloro-8-cyclopentyl-5-Methylpyrido [2,3-d]pyrimidin-7(8H)-one | 1016636-76 | Palbociclib |
| 68 | 7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | 39713-40-1 | Rimegepant |
| 69 | 1190363-46-2 | Rimegepant | |
| 70 | 1373116-04-1 | Rimegepant | |
| 71 | 1,3-Dihydro-1-[1-(1H-imidazol-1-ylcarbonyl)-4-piperidinyl]-2H-imidazo [4,5-b]pyridin-2-one | 1373116-06-3 | Rimegepant |
| 72 | (1S)-2,2,2-trifluoro-1-methylethyl]hydrazine hydrochloride | 2764851-03-6 | Pirtobrutinib |
| 73 | Potassium trifluoro ((5-fluoro-2-methoxybenzamido)methyl)borate | 2089246-64-8 | Pirtobrutinib |
| 74 | 2-[(4-bromophenyl)methoxymethylene] Malononitrile | 1188083-45-5 | Pirtobrutinib |
| 75 | 107228-51-3 | Resmetirom | |
| 76 | 920509-27-9 | Resmetirom | |
| 77 | 920509-28-0 | Resmetirom | |
| 78 | 4/5/6629 | Resmetirom | |
| 79 | 1207853-23-3 | Ritlecitinib | |
| 80 | 90213-66-4 | Ritlecitinib | |
| 81 | 2042650-70-2 | Ritlecitinib | |
| 82 | 1792180-81-4 | Ritlecitinib | |
| 83 | (S)-2-((4-(Trifluoromethyl)phenoxy)methyl)oxirane | 256372-58-4 | Seladelpar |
| 84 | 2-(4-Mercapto-2-methylphenoxy)-acetic acid ethyl este | 343322-82-7 | Seladelpar |
| 85 | 4-Trifluoromethylphenol | 402-45-9 | Seladelpar |
| 86 | 1023742-13-3 | Selumetinib | |
| 87 | 606143-46-8 | Selumetinib | |
| 88 | 391212-29- | Selumetinib | |
| 89 | 2252403-82-8 | Sotorasib | |
| 90 | (S)-4-N-Boc-2-methylpiperazine | 147081-29-6 | Sotorasib |
| 91 | 2-Fluoro-6-methoxyphenylboronic acid | 78495-63-3 | Sotorasib |
| 92 | 1662688-20-1 | Semaglutide | |
| 93 | 1118767-16-0 | Semaglutide | |
| 94 | Sema peptide | 1169630-82-3 | Semaglutide |
| 95 | SNAC | 203787-91-1 | Semaglutide |
| 96 | 3-Amino-4,5-dimethylisoxazole | 13999-39-8 | Sparsentan |
| 97 | 415697-56-2 | Sparsentan | |
| 98 | R-5,7-Difluorochroman-4-ol | 1270294-05-7 | Tegoprazan |
| 99 | 4-Hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[djimidazole-6-carboxamide | 942195-86-0 | Tegoprazan |
| 100 | 1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid | 1640981-19-6 | Tegoprazan |
| 101 | Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA}-OH | 2460751-66-8 | Tirzepatide |
| 102 | 20-(tert-Butoxy)-20-oxoicosanoic acid | 683239-16-9 | Tirzepatide |
| 102 | :1095824-76-2 | Tovorafenib | |
| 103 | 1095824-77-3 | Tovorafenib | |
| 104 | 914916-98-6 | Tovorafenib | |
| 105 | 1-(1,1-Dimethylethyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one | 1455358-06-1 | Ubrogepant |
| 106 | 1375541-21-1 | Ubrogepant | |
| 107 | 1456803-37-4 | Ubrogepant | |
| 108 | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | 1428243-26-8 | Upadacitinib |
| 109 | tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate | 1201187-44-1 | Upadacitinib |
| 110 | 2,2,2-Trifluoroethylamine hydrochloride | 373-88-6 | Upadacitinib |
| 111 | 3-Chloro-4-(pyridin-3-yl)-1,2,5-thiadiazole | 131986-28-2 | Xanomeline |
| 112 | Methyl (2R)-2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate dihydrochloride | 1414976-14-9 | Zavegepant |
| 113 | 3-(Piperidin-4-yl)quinolin-2(1H)-one hydrochloride | 855778-84-6 | Zavegepant |
Disclaimer: Some products listed are currently under development; therefore, detailed information may not be available at this stage. Products that are subject to existing patent protection are offered solely for purposes reasonably related to research, development, and regulatory submission to the relevant Health Authorities, in accordance with applicable laws governing the manufacture, use, and sale of Active Pharmaceutical Ingredients.